BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12814824)

  • 1. [Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy].
    Noblet-Dick M; Grunenberger F; Brunot B; Jaeck D; Schlienger JL
    Rev Med Interne; 2003 Jun; 24(6):358-65. PubMed ID: 12814824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.
    Derlin T; Busch JD; Wisotzki C; Schoennagel BP; Bannas P; Papp L; Klutmann S; Habermann CR
    Clin Nucl Med; 2013 Jan; 38(1):e1-6. PubMed ID: 22996238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
    Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
    Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
    Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
    Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
    Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
    Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pheochromocytoma].
    Arnault-Ouary G; Chatal JF; Charbonnel B
    Rev Prat; 1998 Apr; 48(7):744-8. PubMed ID: 11767369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.
    Lev I; Kelekar G; Waxman A; Yu R
    Endocr Pract; 2010; 16(3):398-407. PubMed ID: 20061293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study.
    Lumachi F; Tregnaghi A; Zucchetta P; Cristina Marzola M; Cecchin D; Grassetto G; Bui F
    Nucl Med Commun; 2006 Jul; 27(7):583-7. PubMed ID: 16794519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
    Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
    Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
    Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting pheochromocytoma: defining the most sensitive test.
    Guller U; Turek J; Eubanks S; Delong ER; Oertli D; Feldman JM
    Ann Surg; 2006 Jan; 243(1):102-7. PubMed ID: 16371743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.
    Greenblatt DY; Shenker Y; Chen H
    Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma.
    Plewe G; Beyer J; Krause U; Cordes U; Eissner D; Hahn K
    Klin Wochenschr; 1985 Jul; 63(14):627-30. PubMed ID: 4032986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.
    Berglund AS; Hulthén UL; Manhem P; Thorsson O; Wollmer P; Törnquist C
    J Intern Med; 2001 Mar; 249(3):247-51. PubMed ID: 11285044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging.
    Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K
    Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.